Neupogen (filgrastim) For Injection, 300mcg/1 mL, 1 mL Single Dose Vials, Rx Onl Supply Disruption — Amgen, Inc. (Moderate Risk —
Neupogen (filgrastim) For Injection, 300mcg/1 mL, 1 mL Single Dose Vials, Rx Onl Supply Disruption — Amgen, Inc. (Moderate Risk — is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Neupogen (filgrastim) For Injection, 300mcg/1 mL, 1 mL Single Dose Vials, Rx Onl; Manufacturer: Amgen,
| Drug name | Neupogen (filgrastim) For Injection, 300mcg/1 mL, 1 mL Single Dose Vials, Rx Onl |
|---|---|
| Manufacturer | Amgen, Inc. |
| Recall/Disruption reason | Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Ongoing |
| Record type | Enforcement/Recall |
| Recall number | D-0285-2025 |
| Initiation date | 20250227 |
| Quantity affected | 313,620 Vials |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →